Morgan, R. D., McNeish, I. A., Cook, A. D., James, E. C., Lord, R., Dark, G., . . . Clamp, A. R. (2021). Objective responses to first-line neoadjuvant carboplatin−paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): Post-hoc exploratory analysis of a randomised, phase 3 trial. Lancet Oncol.
シカゴスタイル引用形Morgan, Robert D., et al. "Objective Responses to First-line Neoadjuvant Carboplatin−paclitaxel Regimens for Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (ICON8): Post-hoc Exploratory Analysis of a Randomised, Phase 3 Trial." Lancet Oncol 2021.
MLA引用形式Morgan, Robert D., et al. "Objective Responses to First-line Neoadjuvant Carboplatin−paclitaxel Regimens for Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (ICON8): Post-hoc Exploratory Analysis of a Randomised, Phase 3 Trial." Lancet Oncol 2021.